|
1. Novo says Wegovy pill trumps Lilly’s orforglipron in key measures Full story
2. FDA rejects melanoma drug, again Full story
3. How WakeMed, Lee Health + Cone Health are transforming OR operations: watch now here.
4. Trump bought Eli Lilly stock as his administration cleared path for Medicare GLP-1 coverage Full story
5. Why generic Ozempic could be delayed in the US: Report Full story
6. 70+ system leaders reveal their biggest operational challenges — and the strategies gaining traction here.
7. FDA approves 1st-in-class blood pressure drug Full story
8. 6 big pharma moves Full story
Becker’s Learning Opportunities
9. Vanderbilt, CHRISTUS and Integris leaders share proactive workplace safety strategies for health systems here.
10. 53 ORs. 54,000 surgeries. One operating model. How Lee Health did it: here.
11. An inherited cardiovascular risk factor just got more attention in updated national guidelines. See why here.
12. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
